Suppl Information from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR<sup>+</sup>/HER2<sup>+</sup> Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
Pei-Yin Hsu, Shiuan Chen(City Of Hope National Medical Center)
Cited by 0
Related Papers
Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway
|Cancer Research|2010|217
Heat Shock Protein 90 Inhibitors: New Mode of Therapy to Overcome Endocrine Resistance
|Cancer Research|2009|34
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer
|Oncotarget|2018|18
Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment
|Clinical and Translational Medicine|2024|12